1. Home
  2. QLGN vs EDBL Comparison

QLGN vs EDBL Comparison

Compare QLGN & EDBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • QLGN
  • EDBL
  • Stock Information
  • Founded
  • QLGN 1996
  • EDBL 2020
  • Country
  • QLGN United States
  • EDBL United States
  • Employees
  • QLGN N/A
  • EDBL N/A
  • Industry
  • QLGN Biotechnology: Pharmaceutical Preparations
  • EDBL Farming/Seeds/Milling
  • Sector
  • QLGN Health Care
  • EDBL Consumer Staples
  • Exchange
  • QLGN Nasdaq
  • EDBL Nasdaq
  • Market Cap
  • QLGN 2.8M
  • EDBL 3.3M
  • IPO Year
  • QLGN N/A
  • EDBL 2022
  • Fundamental
  • Price
  • QLGN $3.75
  • EDBL $2.63
  • Analyst Decision
  • QLGN
  • EDBL
  • Analyst Count
  • QLGN 0
  • EDBL 0
  • Target Price
  • QLGN N/A
  • EDBL N/A
  • AVG Volume (30 Days)
  • QLGN 10.5K
  • EDBL 10.4M
  • Earning Date
  • QLGN 07-01-2025
  • EDBL 05-15-2025
  • Dividend Yield
  • QLGN N/A
  • EDBL N/A
  • EPS Growth
  • QLGN N/A
  • EDBL N/A
  • EPS
  • QLGN N/A
  • EDBL N/A
  • Revenue
  • QLGN N/A
  • EDBL $13,443,000.00
  • Revenue This Year
  • QLGN N/A
  • EDBL $29.56
  • Revenue Next Year
  • QLGN N/A
  • EDBL $20.00
  • P/E Ratio
  • QLGN N/A
  • EDBL N/A
  • Revenue Growth
  • QLGN N/A
  • EDBL N/A
  • 52 Week Low
  • QLGN $2.85
  • EDBL $1.80
  • 52 Week High
  • QLGN $29.44
  • EDBL $55.14
  • Technical
  • Relative Strength Index (RSI)
  • QLGN 51.20
  • EDBL 45.99
  • Support Level
  • QLGN $3.65
  • EDBL $3.20
  • Resistance Level
  • QLGN $3.98
  • EDBL $4.15
  • Average True Range (ATR)
  • QLGN 0.14
  • EDBL 0.66
  • MACD
  • QLGN -0.01
  • EDBL -0.10
  • Stochastic Oscillator
  • QLGN 51.32
  • EDBL 18.49

About QLGN Qualigen Therapeutics Inc.

Qualigen Therapeutics Inc is a early-clinical-stage therapeutics company focused on developing treatments for adult and pediatric cancer. The company's business consists of one early-clinical-stage therapeutic program (QN-302) and one preclinical therapeutic program. The company's lead program, QN-302, is an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor with strong binding affinity to G4s prevalent in cancer cells.

About EDBL Edible Garden AG Incorporated

Edible Garden AG Inc is a next-generation controlled environment agriculture farming company. It uses traditional agricultural growing techniques together with technology to grow fresh, organic food, sustainably and safely while improving traceability. The company uses the controlled environment of traditional greenhouse structures, such as glass greenhouses together with hydroponic and vertical greenhouses to sustainably grow organic herbs and lettuces.

Share on Social Networks: